About   Help   FAQ
Mammalian Phenotype Ontology Annotations
Query Results - Summary
Symbol
Name
ID
Brca2
breast cancer 2, early onset
MGI:109337
95 phenotypes from 16 alleles in 26 genetic backgrounds
Export: Excel File
Allelic Composition
Genetic Background
Annotated Term Reference
Brca2tm1.1Brn/Brca2tm1.1Brn
involves: 129P2/OlaHsd * BALB/cJ * FVB/N
abnormal embryo development J:73028
embryonic growth retardation J:73028
embryonic lethality, complete penetrance J:73028
Brca2tm1.1Sks/Brca2tm1.1Sks
involves: 129 * C57BL/6J * FVB/N
normal reproductive system phenotype J:187434
Brca2tm1Arge/Brca2+
involves: 129S/SvEv * C57BL/6
normal neoplasm J:40594
Brca2tm1Arge/Brca2tm1Arge
involves: 129S/SvEv * C57BL/6
abnormal amnion morphology J:40594
abnormal embryo development J:40594
abnormal extraembryonic tissue morphology J:40594
abnormal proamniotic cavity morphology J:40594
abnormal visceral yolk sac morphology J:40594
decreased embryo size J:40594
embryonic lethality, complete penetrance J:40594
enlarged allantois J:40594
Brca2tm1Arge/Brca2tm2Arge
involves: 129S/SvEv * C57BL/6
no abnormal phenotype detected J:70564
Brca2tm1Arge/Brca2tm2Arge
Waptm1(cre)Arge/Wap+
involves: 129S/SvEv * C57BL/6
increased mammary adenocarcinoma incidence J:70564
Brca2tm1Brd/Brca2+
involves: 129S7/SvEvBrd
no abnormal phenotype detected J:39764
Brca2tm1Brd/Brca2tm1.1Sks
involves: 129 * 129S7/SvEvBrd * C57BL/6J * FVB/N
normal reproductive system phenotype J:187434
Brca2tm1Brd/Brca2tm1Brd
involves: 129S7/SvEvBrd
abnormal developmental patterning J:39764
abnormal embryonic tissue morphology J:39764
abnormal extraembryonic tissue morphology J:39764
prenatal lethality, complete penetrance J:39764
Brca2tm1Brn/Brca2tm1Brn
involves: 129P2/OlaHsd * FVB/N
no abnormal phenotype detected J:73028
Brca2tm1Brn/Brca2tm1Brn
Cd19tm1(cre)Cgn/Cd19+
involves: 129P2/OlaHsd
chromosome breakage J:197442
Brca2tm1Brn/Brca2tm1Brn
Tg(Nes-cre)1Kln/0
involves: 129P2/OlaHsd * C57BL/6 * SJL
normal nervous system phenotype J:144617
Brca2tm1Brn/Brca2tm1Brn
Tg(Pbsn-cre)4Prb/0
involves: 129P2/OlaHsd * C57BL/6 * DBA/2
abnormal prostate gland physiology J:161511
increased prostate intraepithelial neoplasia incidence J:161511
prostate gland hyperplasia J:161511
Brca2tm1Cam/Brca2tm1Brn
Tg(Pdx1-cre)6Tuv/0
involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6 * FVB/N
exocrine pancreatic insufficiency J:166678
premature death J:166678
Brca2tm1Cam/Brca2tm1Cam
129S/SvEv-Brca2tm1Cam
abnormal axial skeleton morphology J:46812
embryonic growth retardation J:46812
neonatal lethality, incomplete penetrance J:46812
postnatal lethality, incomplete penetrance J:46812
prenatal lethality, incomplete penetrance J:46812
Brca2tm1Cam/Brca2tm1Cam
involves: 129S/SvEv
abnormal mitosis J:93261
Brca2tm1Cam/Brca2tm1Cam
involves: 129S/SvEv * MF1
abnormal axial skeleton morphology J:46812
absent germ cells J:46812
embryonic growth retardation J:46812
embryonic lethality during organogenesis, incomplete penetrance J:46812
female infertility J:46812
increased T cell derived lymphoma incidence J:46812
increased thymus weight J:46812
male infertility J:46812
neonatal lethality, incomplete penetrance J:46812
perinatal lethality, incomplete penetrance J:46812
postnatal lethality, incomplete penetrance J:46812
premature death J:46812
Brca2tm1Cbl/Brca2tm1Cbl
either: (involves: 129S2/SvPas * C57BL/10) or (involves: 129S2/SvPas * C57BL/6 * DBA/2)
abnormal double-strand DNA break repair J:44386
abnormal epidermal layer morphology J:44386
abnormal epidermis stratum basale morphology J:44386
abnormal epidermis stratum spinosum morphology J:44386
abnormal rib morphology J:44386
abnormal skin morphology J:44386
abnormal sternum morphology J:44386
absent epidermis stratum corneum J:44386
absent ovarian follicles J:44386
azoospermia J:44386
decreased birth weight J:44386
decreased body weight J:44386
decreased fetal weight J:44386
decreased fibroblast proliferation J:44386
fetal growth retardation J:44386
increased T cell derived lymphoma incidence J:44386
kinked tail J:44386
male infertility J:44386
ovary degeneration J:44386
postnatal lethality, incomplete penetrance J:44386
premature death J:44386
small ovary J:44386
small testis J:44386
Brca2tm1Hst/Brca2tm1Hst
involves: 129S7/SvEvBrd * C57BL/6
decreased tumor latency J:82434
increased carcinoma incidence J:82434
increased lymphoma incidence J:82434
premature death J:82434
sepsis J:82434
Brca2tm1Hst/Brca2tm2Hst
involves: 129S7/SvEvBrd * C57BL/6
chromosomal instability J:82434
early cellular replicative senescence J:82434
Brca2tm1Kamc/Brca2tm1Kamc
involves: 129P2/OlaHsd
small testis J:268570
Brca2tm1Kamc/Brca2tm1Kamc
involves: 129P2/OlaHsd * BALB/c
abnormal chromosome morphology J:144998
abnormal DNA repair J:144998
abnormal hematopoietic system morphology/development J:144998
decreased body weight J:144998
decreased bone marrow cell number J:144998
decreased common myeloid progenitor cell number J:144998
impaired hematopoiesis J:144998
increased mortality induced by ionizing radiation J:144998
increased sensitivity to induced cell death J:144998
spleen hypoplasia J:144998
Brca2tm1Kamc/Brca2tm1Kamc
involves: 129P2/OlaHsd * C57BL/6N
abnormal branching of the mammary ductal tree J:75026
decreased survivor rate J:75026, J:109193
increased tumor incidence J:75026
lethality throughout fetal growth and development, incomplete penetrance J:75026
normal neoplasm J:109193
normal reproductive system phenotype J:75026
Brca2tm1Mak/Brca2tm2Mak
Tg(Lck-cre)548Jxm/0
involves: 129P2/OlaHsd * C57BL/6 * CBA
abnormal chromosome morphology J:79697
aneuploidy J:79697
normal cellular phenotype J:79697
normal immune system phenotype J:79697
increased T cell apoptosis J:79697
normal neoplasm J:79697
Brca2tm1Mbn/Brca2+
B6.Cg-Brca2tm1Mbn ApcMin
adrenal gland hyperplasia J:67445
normal growth/size/body region phenotype J:67445
increased mammary gland tumor incidence J:67445
normal reproductive system phenotype J:67445
Brca2tm1Mbn/Brca2+
involves: 129P2/OlaHsd * 129S/SvEv
abnormal motor capabilities/coordination/movement J:74077
Brca2tm1Mbn/Brca2tm1Mbn
C.129P2-Brca2tm1Mbn
embryonic growth retardation J:74077
embryonic lethality during organogenesis, complete penetrance J:74077
open neural tube J:74077
Brca2tm1Mbn/Brca2tm1Mbn
involves: 129P2/OlaHsd * 129S/SvEv
embryonic lethality between somite formation and embryo turning, complete penetrance J:74077
Brca2tm1Mhun/Brca2+
involves: 129S7/SvEvBrd * C57BL/6J
abnormal cell physiology J:89083
decreased incidence of tumors by chemical induction J:89083
decreased tumor incidence J:89083
increased apoptosis J:89083
Brca2tm1Mhun/Brca2tm1Mhun
involves: 129S7/SvEvBrd * C57BL/6J
embryonic lethality during organogenesis, complete penetrance J:89083
Brca2tm2.1Sks/Brca2tm1Brd
B6.Cg-Brca2tm1Brd Brca2tm2.1Sks
abnormal branching of the mammary ductal tree J:323630
normal behavior/neurological phenotype J:323630
decreased birth body size J:323630
decreased birth weight J:323630
decreased body size J:323630
decreased body weight J:323630
decreased embryo size J:323630
decreased mammary duct terminal end bud number J:323630
normal embryo phenotype J:323630
normal growth/size/body region phenotype J:323630
increased mortality induced by ionizing radiation J:323630
normal neoplasm J:323630
premature death J:323630
prenatal lethality, incomplete penetrance J:323630
normal reproductive system phenotype J:323630
Brca2tm2.1Sks/Brca2tm2.1Sks
Not Specified
decreased embryo size J:323630
normal embryo phenotype J:323630
normal homeostasis/metabolism phenotype J:323630
normal mortality/aging J:323630
normal neoplasm J:323630
prenatal lethality, incomplete penetrance J:323630
normal reproductive system phenotype J:323630
Brca2tm2Arge/Brca2tm2Arge
Waptm1(cre)Arge/Waptm1(cre)Arge
involves: 129S1/Sv * C57BL/6
increased mammary adenocarcinoma incidence J:70564
Brca2tm2Hst/Brca2tm2Hst
involves: 129S7/SvEvBrd * C57BL/6
embryonic lethality, complete penetrance J:82434
Brca2tm2Mak/Brca2tm2Mak
involves: 129P2/OlaHsd * C57BL/6
no abnormal phenotype detected J:79697

Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
12/10/2024
MGI 6.24
The Jackson Laboratory